American Conference Institute's 6th National Conference on Managing Legal Risks in Structuring & Conducting Clinical Trials
February 27, 2007
The American Conference Institute’s 6th National Conference on Managing Legal Risks in Structuring & Conducting Clinical Trials will take place February 27-28, 2007 at the Roosevelt Hotel in New York. Legal and compliance experts from pharmaceutical and medical device companies, Contract Research Organizations (CROs), and hospital and research institutions, as well as attorneys will provide an intensive and thorough review of the critical issues that arise in ensuring proper management of protocols, contracts, consents, and other documents.
On February 27, Securities Litigation, Enforcement & Regulation senior counsel Elizabeth Gray will present Reacting to Scrutiny of Clinical Trial Disclosures by the SEC which will review the following:
- How FDA and SEC cooperation (Referral Process and Centralized Procedures) have affected scrutiny of clinical trial disclosures
- Complying with SEC reporting requirements pre- and post-approval
- Reconciling FDA/SEC disclaimer requirements
- Factoring in recent enforcement activities by the SEC and FDA
- Lessons learned from ImClone, TKT, ICN, and NY Executive Law 63(12)
- Disclosing clinical trial information that has been made available to the FDA but not publicly disclosed
- Determining what FDA actions to disclose and how to disclose them for accurate interpretation by the securities market
- Alleviating securities concerns: whether databank entries constitute “forward-looking statements” for investor reliance
- Controlling and monitoring material inside information
Related Insights
May 29, 2026
Foley Viewpoints
SEC Proposes Significant Reforms to Registered Offering Framework
On May 19, 2026, the Securities and Exchange Commission (SEC) proposed sweeping amendments to its rules and forms governing registered…
May 29, 2026
Foley Corporate Governance Update
DExit One Year Later: An Assessment of SB21, the Continuing Pace of Reincorporation and the Maturation of Texas as a Corporate Domicile
When I last addressed the so-called DExit phenomenon, Delaware’s General Assembly had just enacted Senate Bill 21 in response to the growing concern that public companies, prompted by a series of decisions from the Delaware Court of Chancery, most prominently Tornetta v. Musk, were reconsidering their historical preference for incorporation in Delaware.
May 28, 2026
Foley Viewpoints
AI Transcription Tools in Health Care: What In-House Counsel Needs to Get Right
AI is changing health care faster than almost any other technology in recent memory. Among the most rapidly adopted applications are transcription tools that record encounters, convert speech to text, generate draft notes, and support scheduling, intake, triage, and other administrative workflows.